Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Oncotarget|April 22, 2017
The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BLSanghoon Lee, Wen Luo, Tishi Shah, et al.Pediatric Blood & Cancer|May 22, 2008
Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study groupRodney R Miles, Martine Raphael, Keith McCarthy, et al.British Journal of Haematology|October 11, 2011
Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expressionJoshua D Schiffman, Patrick D Lorimer, Vladimir Rodic, et al.Cell Reports|October 27, 2016
MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor CellsKatarzyna Modzelewska, Elena F Boer, Timothy L Mosbruger, et al.Nature Communications|February 9, 2020
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricideSabarinath V Radhakrishnan, Tim Luetkens, Sandra D Scherer, et al.Leukemia|August 17, 2018
Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesisChiara Borga, Gilseung Park, Clay Foster, et al.Pediatric Blood & Cancer|December 14, 2016
Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissuesJulia A Meyer, Delu Zhou, Clinton C Mason, et al.Leukemia Research|February 15, 2017
Genomic analysis of adult B-ALL identifies potential markers of shorter survivalShiven Patel, Clinton C Mason, Martha J Glenn, et al.Blood Advances|July 23, 2021
Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphomaXinjie Xu, Christian N Paxton, Robert J Hayashi, et al.Oncoimmunology|December 15, 2018
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) modelYaya Chu, Sanghoon Lee, Tishi Shah, et al.Pageof 5